Quick Takeaways
- Rory B. Riggs has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $34,791,860.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Rory B. Riggs and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CBUS | Cibus, Inc. | Director, 10%+ Owner | $22,452,878 | 29 Jan 2026 | ||
| RPRX | Royalty Pharma plc | Director | $11,577,870 | 20 Feb 2024 | ||
| KYNB | FIBROGEN INC | Director | $761,112 | 26 May 2021 | ||
| ITCI | Intra-Cellular Therapies, Inc. | Director | $0 | 02 Apr 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|